CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
87 hedge funds and large institutions have $202M invested in Concert Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
13% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 23
Holders
87
Holding in Top 10
–
Calls
$3.21M
Puts
$2.92M
Top Buyers
| 1 | +$7.82M | |
| 2 | +$5.52M | |
| 3 | +$2.91M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$2.66M |
| 5 |
ISL
Ingalls & Snyder LLC
New York
|
+$2.16M |
Top Sellers
| 1 | -$20.4M | |
| 2 | -$5.47M | |
| 3 | -$3.63M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.33M |
| 5 |
Renaissance Technologies
New York
|
-$1.05M |